APA (7th ed.) Citation

JD, G., NB, S., MH, P., LH, K., J, B., N, L., . . . OS, S. (2021). Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine, 35, 100849. https://doi.org/10.1016/j.eclinm.2021.100849

Chicago Style (17th ed.) Citation

JD, Gunst, et al. "Efficacy of the TMPRSS2 Inhibitor Camostat Mesilate in Patients Hospitalized with Covid-19-a Double-blind Randomized Controlled Trial." EClinicalMedicine 35 (2021): 100849. https://doi.org/10.1016/j.eclinm.2021.100849.

MLA (9th ed.) Citation

JD, Gunst, et al. "Efficacy of the TMPRSS2 Inhibitor Camostat Mesilate in Patients Hospitalized with Covid-19-a Double-blind Randomized Controlled Trial." EClinicalMedicine, vol. 35, 2021, p. 100849, https://doi.org/10.1016/j.eclinm.2021.100849.